ClinicalTrials.Veeva

Find clinical trials for Endometrial Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Houston, TX, USA:

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will al...

Active, not recruiting
Endometrial Cancer
Drug: RAD001 (Everolimus)
Drug: Letrozole

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States and 1 other location

To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Dostarlimab

Phase 1

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Enrolling
Endometrial Cancer
Drug: INCAGN02390
Drug: pemigatinib

Phase 2

Incyte
Incyte

Shenandoah, Texas, United States and 66 other locations

To learn if the combination of DKN-01 and pembrolizumab can help to control advanced or recurrent endometrial cancer....

Enrolling
Endometrial Cancer
Drug: DKN-01
Drug: Pembrolizumab

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

ImmunoGen

Houston, Texas, United States and 5 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Biological: durvalumab
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Houston, Texas, United States and 202 other locations

compared to Tamoxifen and Medroxyprogesterone acetate in treating endometrial cancer and to determine the types and severity of sid...

Active, not recruiting
Advanced, Persistent, or Recurrent Endometrial Cancer
Drug: Medroxyprogesterone Acetate
Drug: Tamoxifen

Phase 2

GOG Foundation

Houston, Texas, United States and 25 other locations

and metformin can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will also be stu...

Active, not recruiting
Endometrial Cancer
Drug: Letrozole
Drug: Metformin

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States and 5 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Houston, Texas, United States and 75 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Pembrolizumab
Drug: Doxorubicin

Phase 3

Eisai
Eisai

Houston, Texas, United States of America and 168 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems